Blinatumomab
Products in Health Canada’s databases that list Blinatumomab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 1
- 1 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 15
- Products in all
- 1
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| BLINCYTO (38.5 MCG) | 02450283 | Marketed | Amgen Canada Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- BLINCYTOFebruary 27, 2026 · NOC 37013
- BLINCYTOAugust 1, 2025 · NOC 36185
- BLINCYTODecember 27, 2024 · NOC 34618
- BLINCYTOApril 26, 2024 · NOC 33145
- BLINCYTOAugust 29, 2023 · NOC 31519
- BLINCYTOMarch 22, 2023 · NOC 30375
- BLINCYTOMay 6, 2021 · NOC 25818
- BLINCYTODecember 19, 2019 · NOC 23036
- BLINCYTOJune 8, 2018 · NOC 20952
- BLINCYTOMarch 5, 2018 · NOC 20555
- BLINCYTOFebruary 2, 2018 · NOC 20434
- BLINCYTONovember 16, 2017 · NOC 20062
- BLINCYTOApril 28, 2017 · NOC 19222
- BLINCYTOAugust 30, 2016 · NOC 18410
- BLINCYTODecember 22, 2015 · NOC 17601